- Home
- ZTEK vs BYSI Comparison
ZTEK vs BYSI Comparison
Compare ZTEK & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.52
HOLD
Current Price
$1.62
Company Overview
Basic Information| Metric | ZTEK | BYSI |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.8M | 67.9M |
| IPO Year | 2022 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ZTEK | BYSI |
|---|---|---|
| Price | $0.52 | $1.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 71.2K | 22.2K |
| Earning Date | 02-18-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.52 | $0.98 |
| 52 Week High | $1.84 | $3.44 |
Technical Indicators
Market Signals| Indicator | ZTEK | BYSI |
|---|---|---|
| Relative Strength Index (RSI) | 26.30 | 51.84 |
| Support Level | N/A | $1.38 |
| Resistance Level | $0.75 | $1.83 |
| Average True Range (ATR) | 0.04 | 0.14 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 2.94 | 42.53 |
Price Performance
Historical Comparison ZTEK
BYSI
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.